Viracta Therapeutics Inc. (VIRX)
undefined
undefined%
At close: undefined
0.23
6.97%
Pre-market Jan 07, 2025, 05:20 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income -51.06M -49.20M -114.76M -19.02M -23.33M -26.61M -35.46M -38.02M -36.68M -43.00M -34.60M -43.95M -20.14M -24.59M -40.23M -37.19M -38.76M -31.24M -27.50M -20.53M
Depreciation & Amortization 492.00K 210.00K 178.00K 32.00K 3.13K 9.00K 9.00K 11.00K 27.00K 29.00K 20.00K 31.00K 56.00K 150.23K 341.58K 1.10M 1.73M 1.58M 1.68M 2.17M
Stock-Based Compensation 7.65M 13.55M 5.54M 348.00K 627.61K 210.59K 4.79M 4.79M 6.34M 6.22M 3.88M 2.72M 1.39M 877.22M 1.34B 1.91B 3.19B 2.88B 1.27B n/a
Other Working Capital 5.18M 969.00K 758.00K 1.60M -48.00K -323.00K -3.82M -3.54M -4.29M 7.58M -35.55M 4.49M -5.08M 40.26M -3.13M 300.53M -1.09B -417.96M -386.43M 6.65M
Other Non-Cash Items -2.05M -626.00K 88.22M 12.00K 2.40M 3.15M 3.49M 5.78M 3.71M -16.23M 27.94M 26.64M 697.35K -36.13M 21.93M 33.05M 18.15M -12.55M 9.27M 618.49K
Deferred Income Tax n/a n/a 290.00K n/a -602.63K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.19B -2.88B -1.27B n/a
Change in Working Capital 5.08M 608.00K 1.68M 2.57M -650.00K -627.00K -4.00M -4.13M -5.02M 9.80M -34.67M 3.91M -4.84M 40.31M -3.56M -34.34M -15.57M 15.12M -4.40M 7.33M
Operating Cash Flow -39.89M -35.46M -18.85M -16.05M -22.18M -24.40M -36.14M -36.96M -38.73M -43.18M -37.42M -10.64M -22.84M -19.38M -20.18M -35.46M -34.46M -27.08M -20.95M -10.41M
Capital Expenditures -138.00K -45.00K -4.25M -55.00K n/a n/a -26.00K n/a n/a -48.00K n/a n/a -15.00K -64.19K -6.14K -179.15K -1.51M -2.30M -1.70M -1.17M
Acquisitions n/a n/a 17.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -67.14M -70.62M n/a -747.00K -20.04M n/a -35.53M -35.53M -35.68M -42.46M -26.89M -67.61M -52.08M -46.64M -503.11K -25.90M -92.68M -68.04M -36.58M -35.26M
Sales Maturities Of Investments 82.27M 16.80M n/a 17.15M 3.75M 4.78M 29.77M 20.53M 36.93M 45.84M 59.11M 46.23M 56.24M 7.51M 4.82M 57.48M 113.84M 41.67M 35.19M 29.32M
Other Investing Acitivies n/a 0.00 13.14M -16.41M n/a n/a 35.53M n/a n/a n/a n/a 11.00K 34.00K 104.25K 391.17K 876.30K 5.12K n/a 86.72K n/a
Investing Cash Flow 15.00M -53.87M 12.89M -55.00K -16.29M 4.78M 29.75M -15.00M 1.25M 3.33M 32.22M -21.37M 4.18M -39.08M 4.70M 32.27M 19.66M -28.67M -3.01M -7.11M
Debt Repayment n/a 19.99M -234.00K 5.26M -2.05M n/a -7.62M 6.75M -1.64M -9.36M -7.18M 14.98M 9.63M n/a n/a -2.31M 465.66K -532.58K -3.36M 311.55K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 139.00K 225.00K 339.00K 77.74M n/a n/a n/a n/a n/a n/a n/a 3.12M n/a n/a n/a -2.24B n/a n/a n/a n/a
Financial Cash Flow 438.00K 22.54M 62.42M 44.98M 43.03M 6.34M 25.32M 33.13M 42.18M 46.92M 5.39M 37.64M 13.75M 68.43M 13.45M -2.24M 20.45M 44.13M 34.07M 14.63M
Net Cash Flow -24.46M -66.78M 56.47M 28.87M 4.57M -13.28M 18.92M -18.83M 4.70M 7.07M 181.00K 5.63M -4.91M 9.96M -2.04M -5.43M 5.65M -11.63M 10.12M n/a
Free Cash Flow -40.03M -35.50M -23.10M -16.11M -22.18M -24.40M -36.17M -36.96M -38.73M -43.23M -37.42M -10.64M -22.85M -19.44M -20.19M -35.64M -35.97M -29.39M -22.65M -11.58M